Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy (Q47837076)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 10 July 2014

Language	Label	Description	Also known as
English	Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy	scientific article published on 10 July 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

1 reference

based on heuristic

inferred from title

Muammer Karadeniz

5

object named as

Muammer Karadeniz

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

Yigit Uyanıkgil

object named as

Yigit Uyanıkgil

4

1 reference

ORCID Public Data File 2021

author name string

Tugba Karadeniz

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

Turker Cavusoğlu

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

Engin Turkmen

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

Ovunc Akdemir

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

M Ibrahim Tuglu

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

Utku Ates

8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

Oytun Erbas

9

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

publication date

10 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

36

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

1283-1290

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

Diabetic nephropathy: diagnosis, prevention, and treatment

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C.

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007.

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia-reperfusion injury.

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Renin-angiotensin system modulates oxidative stress-induced endothelial cell apoptosis in rats

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Early upregulation of iNOS mRNA expression and increase in NO metabolites in pressurized renal epithelial cells

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.930331

21 January 2018

Identifiers

10.3109/0886022X.2014.930331

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/25010195

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47837076&oldid=2172488109"